- Home
- STT vs DXCM Comparison
STT vs DXCM Comparison
Compare STT & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STT | DXCM |
|---|---|---|
| Founded | 1792 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | STT | DXCM |
|---|---|---|
| Price | $127.70 | $67.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $127.92 | $87.90 |
| AVG Volume (30 Days) | 1.6M | ★ 5.2M |
| Earning Date | 01-16-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ 49.61 | 7.75 |
| EPS | ★ 9.43 | 1.80 |
| Revenue | ★ $13,626,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $8.21 | $17.41 |
| Revenue Next Year | $4.53 | $12.78 |
| P/E Ratio | ★ $13.74 | $38.37 |
| Revenue Growth | 8.59 | ★ 14.21 |
| 52 Week Low | $72.81 | $54.11 |
| 52 Week High | $130.03 | $93.25 |
Technical Indicators
Market Signals| Indicator | STT | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 69.76 | 61.23 |
| Support Level | $122.04 | $64.00 |
| Resistance Level | $124.21 | $69.77 |
| Average True Range (ATR) | 2.58 | 1.94 |
| MACD | 1.13 | 0.78 |
| Stochastic Oscillator | 79.69 | 73.51 |
Price Performance
Historical ComparisonAbout STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.